BioRestorative Therapies Inc expected to post a loss of 28 cents a share - Earnings Preview

Biorestorative Therapies

25/03/2025 20:32

BioRestorative Therapies Inc BRTX.OQ BRTX.O is expected to show a rise in quarterly revenue when it reports  results on March 27 for the period ending December 31 2024

The Melville New York-based  company is expected to report a 2,400.0% increase in revenue to $475 thousand from $19 thousand a year ago, according to the mean estimate from 2 analysts, based on LSEG data.

​LSEG's mean analyst estimate for BioRestorative Therapies Inc is for a loss of 28 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for BioRestorative Therapies Inc is $13.00​, above​ its last closing price of $1.97. ​​​

This summary was machine generated March 25 at 20:32 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)